chr20-31819584-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_033118.4(MYLK2):c.4G>A(p.Ala2Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00181 in 1,551,566 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A2V) has been classified as Uncertain significance.
Frequency
Consequence
NM_033118.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYLK2 | NM_033118.4 | c.4G>A | p.Ala2Thr | missense_variant | 2/13 | ENST00000375985.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYLK2 | ENST00000375985.5 | c.4G>A | p.Ala2Thr | missense_variant | 2/13 | 1 | NM_033118.4 | P1 | |
MYLK2 | ENST00000375994.6 | c.4G>A | p.Ala2Thr | missense_variant | 1/12 | 1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00141 AC: 214AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000831 AC: 130AN: 156500Hom.: 0 AF XY: 0.000814 AC XY: 67AN XY: 82336
GnomAD4 exome AF: 0.00185 AC: 2592AN: 1399266Hom.: 1 Cov.: 31 AF XY: 0.00181 AC XY: 1247AN XY: 690128
GnomAD4 genome AF: 0.00141 AC: 214AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.00133 AC XY: 99AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:5
Likely benign, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2021 | This variant is associated with the following publications: (PMID: 25188385, 26595808, 23861362, 26423924, 24503780) - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | MYLK2: BS1 - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 05, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 10, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Ala2Thr varia nt in MYLK2 has been identified by our laboratory in 1 adult with DCM, 1 adult w ith HCM, 1 child with biventricular hypertrophy and dysfunction, and 1 child wit h possible LVNC/DCM who also carried a pathogenic variant in MYH7. The p.Ala2Thr variant has also been identified in 0.2% (143/72280) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSN P rs117502839). Arginine (Arg) at position 2 is not conserved in mice, which car ry a threonine (Thr) at this position, raising the possibility that this change may be tolerated. Additional computational prediction tools do not provide stron g support for or against an impact to the protein. In summary, while the clinic al significance of the p.Ala2Thr variant is uncertain, its frequency and lack of conservation in mice suggest that it is more likely to be benign. - |
Hypertrophic cardiomyopathy 1 Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 03, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 22, 2024 | - - |
MYLK2-related disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 11, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Dec 31, 2020 | - - |
Long QT syndrome;C0042514:Ventricular tachycardia;C0878544:Cardiomyopathy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego | May 08, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at